CompanyPTC Therapeutics
Stock QuoteNASDAQ: PTCT
Study NameVatiquinone (MOVE-FA)
TreatmentFriedreich ataxia
StatusNew Drug Application (NDA)
Catalyst DateAugust 19, 2025
CatalystPDUFA Date
AnnouncementRead More
WebsiteClick Here

See Full FDA Calendar